Opportunity
Simpler Grants.gov #RFA-CA-27-003
Funding for Radiation Oncology-Biology Integration Network (ROBIN) Centers
Buyer
National Cancer Institute
Posted
June 02, 2026
Respond By
January 25, 2027
Identifier
RFA-CA-27-003
NAICS
541715, 541714
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), is seeking applications to establish and support Radiation Oncology-Biology Integration Network (ROBIN) Centers: - Purpose: Fund multidisciplinary research centers focused on understanding biological responses to radiation therapy in cancer patients - Research scope: - Longitudinal studies collecting biospecimens and multimodal data before, during, and after radiation therapy - Investigation of mechanisms of response, resistance, toxicity, and therapy-induced targets - Integration of expertise in biology, clinical oncology, imaging, dosimetry, omics, biospecimen science, and data science - Goal: Accelerate discoveries to inform future clinical trials and improve cancer care - No specific OEMs, vendors, products, or part numbers are identified in this opportunity - Eligibility: Open to government, educational, business, nonprofit, and foreign organizations, including federal agencies - Notable requirements: - Emphasis on national research infrastructure and collaboration - Collection and analysis of biospecimens and complex data sets - Multidisciplinary team composition required
Description
The National Cancer Institute (NCI) seeks to continue support for the Radiation Oncology-Biology Integration Network (ROBIN) through this Notice of Funding Opportunity (NOFO). The network focuses on translational research to understand biological responses in cancer patients undergoing radiation therapy, aiming to improve radiation-based cancer care and identify new combination therapies. ROBIN centers conduct multidisciplinary studies collecting biospecimens and data before, during, and after radiation therapy to reveal mechanisms of response, resistance, and toxicity. The initiative also aims to strengthen the radiation oncology workforce by integrating diverse expertise and sustaining a national research infrastructure.